These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1990732)

  • 1. Return of tuberculosis: screening and preventive therapy.
    Dowling PT
    Am Fam Physician; 1991 Feb; 43(2):457-67. PubMed ID: 1990732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre.
    Aisu T; Raviglione MC; van Praag E; Eriki P; Narain JP; Barugahare L; Tembo G; McFarland D; Engwau FA
    AIDS; 1995 Mar; 9(3):267-73. PubMed ID: 7755915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for tuberculosis in the primary care setting.
    Mackin LA
    Lippincotts Prim Care Pract; 1998; 2(6):599-610; quiz 611-3. PubMed ID: 9883155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of tuberculin skin test screening in a rural family practice.
    Cornell JT; Frame PS; Franks P
    J Fam Pract; 1985 Dec; 21(6):455-9. PubMed ID: 4067527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient management of tuberculosis.
    McColloster P; Neff NE
    Am Fam Physician; 1996 Apr; 53(5):1579-94. PubMed ID: 8623687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis skin testing and preventive therapy.
    Hanson CA; Reichman LB
    Semin Respir Infect; 1989 Sep; 4(3):182-8. PubMed ID: 2688001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed opportunities for tuberculosis prevention.
    McAnulty JM; Fleming DW; Hawley MA; Baron RC
    Arch Intern Med; 1995 Apr; 155(7):713-6. PubMed ID: 7695459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis chemoprophylaxis.
    Salpeter S
    West J Med; 1992 Oct; 157(4):421-4. PubMed ID: 1462535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of preventive chemotherapy in the present tuberculosis epidemiology of GDR (author's transl)].
    Krebs A
    Z Erkr Atmungsorgane; 1977; 147(1):18-25. PubMed ID: 868133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.
    Cohn DL
    Clin Infect Dis; 2000 Jul; 31(1):120-4. PubMed ID: 10913407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of latent tuberculosis infection in patients aged > or =35 years.
    Gilroy SA; Rogers MA; Blair DC
    Clin Infect Dis; 2000 Sep; 31(3):826-9. PubMed ID: 11017843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease.
    Graham NM; Galai N; Nelson KE; Astemborski J; Bonds M; Rizzo RT; Sheeley L; Vlahov D
    Arch Intern Med; 1996 Apr; 156(8):889-94. PubMed ID: 8774208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tuberculosis outbreak in a junior high school in Kochi City--studies on factors relating to extent of tuberculosis infection and the efficacy of isoniazid chemoprophylaxis].
    Toyota M; Morioka S
    Kekkaku; 2001 Sep; 76(9):625-34. PubMed ID: 11676120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public health and preventive aspects of pulmonary tuberculosis. Infectiousness, epidemiology, risk factors, classification, and preventive therapy.
    Leff A; Geppert EF
    Arch Intern Med; 1979 Dec; 139(12):1405-10. PubMed ID: 518223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Persistence of mycobacteria in the host: epidemiology, immunopathology and prophylaxis].
    Mauch H
    Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):152-61. PubMed ID: 8333893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H; Uthaivoravit W; Mastro TD; Limpakarnjanarat K; Sawanpanyalert P; Morrow RH; Nieburg P
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):427-34. PubMed ID: 9441097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive PPD and chemoprophylaxis for tuberculosis infection.
    Pickwell SM
    Am Fam Physician; 1995 Jun; 51(8):1929-34, 1937-8. PubMed ID: 7762484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.